GST Penalty Dropped for Subsidiary of Zydus Lifesciences Ltd
Zydus Lifesciences Ltd reports that German Remedies Pharmaceuticals Private Limited (GRPPL), a wholly owned subsidiary of Zydus Healthcare Limited and a subsidiary of the company, has successfully had a penalty order dropped following an appeal. The penalty related to the alleged excess availment of Input Tax Credit for the financial year 2018-19.The company initially informed stakeholders that GRPPL had received a Demand Order-In-Original pertaining to a penalty of Rs. 1.66 million for the financial year 2018-19.GRPPL subsequently filed an appeal against this order before the Office of the Commissioner, Central GST, Appeal Ahmedabad Commissionerate.The company confirmed...